Yesterday, CMS and CMMI announced a new model that will test strategies to improve medication adherence among Part D beneficiaries. The goal of the “Enhanced Medication Therapy Management (MTM) Model” is to provide better value and improved health outcomes for Part D beneficiaries. The enhanced model will begin January 1, 2017 with a 5 year performance period and will be tested in five different Part D regions. Eligible stand-alone PDPs in these regions will able to vary the intensity and range of MTM services that are provided to beneficiaries, pending CMS approval. The objectives of the model allow for PDPs to “right-size” their investment in MTM services while also allowing for the development of innovative MTM services that leverage the advantages of a given organization. CMS is currently accepting applications from organizations that wish to participate.